XML 72 R63.htm IDEA: XBRL DOCUMENT v3.22.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Net Income (Loss) Attributable to Parent [Abstract]        
Net income attributable to AdaptHealth Corp $ 14,032 $ 79,107 $ 55,782 $ 75,141
Less: Earnings allocated to participating securities (1) 1,186 6,908 4,721 7,431
Net income for basic EPS 12,846 72,199 51,061 67,710
Change in fair value of warrant liability 8,208 (37,454) (18,509) (40,622)
Change in fair value of contingent consideration - common shares liability, net of tax   (18,357)   (19,991)
Net income for diluted EPS $ 12,846 $ 16,388 $ 32,552 $ 7,097
Denominator:        
Basic weighted-average common shares outstanding 134,332,000 129,664,000 134,178,000 120,438,000
Add: Warrants (2)   2,554,000 1,313,000 2,736,000
Add: Contingent Consideration Shares   2,000,000   2,000,000
Diluted weighted average common shares outstanding 137,015,000 136,582,000 138,335,000 127,720,000
Basic net income per share $ 0.10 $ 0.56 $ 0.38 $ 0.56
Diluted net income per share $ 0.09 $ 0.12 $ 0.24 $ 0.06
Anti-dilutive securities excluded (in shares) 14,433,000 12,406,000 13,210,000 13,217,000
Anti-dilutive securities excluded diluted net income per share (in shares) 1,000,000   1,000,000  
Preferred Stock        
Denominator:        
Anti-dilutive securities excluded (in shares) 12,406,000 12,406,000 12,406,000 13,217,000
Warrants        
Denominator:        
Anti-dilutive securities excluded (in shares) 1,168,000      
Stock Options        
Denominator:        
Add: Stock options 2,472,000 1,533,000 2,597,000 1,641,000
Unvested restricted stock        
Denominator:        
Add: Unvested restricted stock 211,000 831,000 247,000 905,000
Anti-dilutive securities excluded (in shares) 391,000   336,000